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Determination of cell signalling behaviour is crucial for understanding the physiological response to a
specific stimulus or drug treatment. Current approaches for large-scale data analysis do not effectively
incorporate critical topological information provided by the signalling network. We herein describe a
novel model- and data-driven hybrid approach, or signal transduction score flow algorithm, which allows
quantitative visualization of cyclic cell signalling pathways that lead to ultimate cell responses such as
survival, migration or death. This score flow algorithm translates signalling pathways as a directed graph
and maps experimental data, including negative and positive feedbacks, onto gene nodes as scores, which
then computationally traverse the signalling pathway until a pre-defined biological target response is
attained. Initially, experimental data-driven enrichment scores of the genes were computed in a pathway,
then a heuristic approach was applied using the gene score partition as a solution for protein node
stoichiometry during dynamic scoring of the pathway of interest. Incorporation of a score partition during
the signal flow and cyclic feedback loops in the signalling pathway significantly improves the usefulness of
this model, as compared to other approaches. Evaluation of the score flow algorithm using both
transcriptome and ChIP-seq data-generated signalling pathways showed good correlation with expected
cellular behaviour on both KEGG and manually generated pathways. Implementation of the algorithm
as a Cytoscape plug-in allows interactive visualization and analysis of KEGG pathways as well as
user-generated and curated Cytoscape pathways. Moreover, the algorithm accurately predicts
gene-level and global impacts of single or multiple in silico gene knockouts.
Introduction
Recent genomic data collections have become publicly avail-
able for whole genomes of several species during the last
decade. In parallel, omics-wide experimental technologies
have been developed. Combined with the advent of supporting
bioinformatics tools, the high-throughput technology has been
commonly exploited in a range of disease conditions such as
cancer and neurodegenerative pathologies.1 These large-scale
biological datasets are often integrated and represented in
various forms of cell signalling networks, which are composed
of a group of biomolecules working together to control cellular
behaviour in response to a signal. It is widely recognized that
a coordinated response of a combination of genes is respon-
sible for most cellular behaviour and related phenotypes.2–4
Hence, studying the complex architecture of signalling networks
with novel algorithmic approaches with the experimental data
can demonstrate how complex biological traits arise and
propagate.
Traditional transcriptomics data-analysis methods identify
a list of significant genes that are expected to be related to a
particular cellular phenotype. However, analysis of the large-
scale experimental data based only on a list of significant genes
falls short of revealing the molecular basis of cellular events.
Therefore, specific methodologies to manipulate and analyse
these data collections still remain to be developed.
Cell signalling networks are often represented in the form of
node-edge structured graphs. The nodes (vertices) and edges of
these graphs represent biomolecules (proteins or small molecules)
and physical interactions between them, respectively. KEGG,5
BioGRID6 and Reactome7 are some of the data sources often
used for integration of omics data into cell signalling networks.
Several bioinformatics tools have been developed to associate
large-scale data, especially microarray gene expression, with
pathway graphs.8–15 These tools aim to interpret the expression
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profiles by identifying experimental condition related genes or
pathways based on traditional statistical tests. Hence they
generate gene co-expression networks of only the selected pool
of genes. Most of the methods perform pathway analysis based on
either significant gene sets or gene functional class identifications.
Although some tools provide quantitative enrichment scores for
the genes or gene-groups, they do not use the topological structure
of the pathway or the biological activity of a specific sub-cellular
process responsible for the observed phenotype. Therefore, this
study aims to design and implement a signal transduction score
flow algorithm to quantitatively assess biological activities of
cellular processes and to identify significant sub-paths (down-
stream process) within that pathway using not only a selected
subset of genes but for all the gene nodes in a given pathway.
We previously described a feed-forward score flow algorithm
for large-scale data annotation and its relation to cellular
networks.16 Our current study focuses on the design and
implementation of a signal transduction score flow algorithm
that quantitatively assesses biological activities of a cyclic
cellular network and identifies significant sub-paths and target
cellular processes in a given pathway. The cyclic network
algorithm was also implemented as a Cytoscape plug-in, then
applied on 30 different KEGG pathways by using two different
data sets. Significance analysis of final activity scores of target
processes was performed. In silico knock-out studies were
analysed on a curated pathway. Our approach fuses and
exploits both data and model, effectively benefiting from topo-
logical information brought in by cell signalling pathways.
A pathway was converted into a graph and the individual gene
scores were mapped onto the nodes of the graph. Gene scores
were transferred en route to the biological pathway to form a
final activity score, describing the behaviour of a specific
process in the pathway while enriching the gene node scores.
Methods
Pathway node score calculation
Based on the omics data, an initial score was assigned to each
protein node of a given pathway. The protein node scores were
obtained by taking products of the rank scores extracted from
experimental data (explained in Raw Data Preparation
Documentation, ESIw). Initial raw data analysis for micro-
array and ChIP-seq was done by R and CisGenome frame-
works respectively.17 Then score computation on the pathway
with the partitioned score transfer procedure was initiated.
Usually, cell signaling flows from cell membrane towards the
nucleus in order to activate certain cellular activities upon a
signal from receptors. Therefore our algorithm simulates this
signal flow after the initial score assignment. First the nodes
(proteins), which are close to the membrane transmit their scores
to their immediate edges, then to nodes in their immediate
neighborhood. If a protein has two or more interacting
partners in the immediate neighborhood, the initial score of
the protein is partitioned to the interacting edges based on the
weights of the interacting neighborhood nodes’ raw data score
(Fig. 1). Then the new edge score and the interacting node
score are added up in order to calculate the output of the next
step in the signaling path. The partitioning idea of this
approach is based on the stoichiometric concentrations of
protein–protein interactions. The number of interactions/
reactions in a cellular system is based on the substance
concentration; therefore we adopted raw data scores as the
stoichiometric concentrations of the node and partitioned raw
data scores, based on their interacting partners’ stoichiometric
concentrations. A fraction of the raw data score is transferred
to one neighbour based on its raw score while the rest of the
raw data score is transferred to the other interacting partner.
During the transfer if the edge is of inhibitory type, then the
edge has a negative value on the interacting partner (Fig. 1).
However when there is negative or positive feedback, score
calculation cannot be solved with the above-explained pro-
cedure. Therefore, we applied a modified breadth-first search
(BFS) algorithm to overcome this problem (see Algorithm 1).
The algorithm had to iterate 10–15 times over the entire cyclic
graph until the convergence of gene node scores was attained.
Fig. 2 illustrates the general process diagram of our pathway
node score flow algorithm.
The score flow calculation algorithm was implemented as a
Cytoscape plug-in (ESIw) and it is publicly available. This
plug-in can be used by following the directions given in the
ESI.w Score calculation can be performed on custom (manually)
generated pathways as well as KEGG pathways.
In addition, in order to evaluate the significance of scores
obtained with the algorithm, we randomized input data several
times and reran the algorithm to calculate new activity scores.
Then p-values of pathway enrichment scores were calculated
so that the consistencies of the final activity scores could be
assessed and demonstrated.
Datasets
We applied the score flow algorithm to two datasets: ChIP-seq
and expression array data sets from Estradiol-treated MCF7
breast cancer cells (GSE11352 and GSE19013) obtained
simultaneously,18,19 and the gene expression profile of the
Colo741 cell line transfected by KRas-G12D or KRas-G12V
mutant proteins (GSE12398).20 The datasets were pre-processed
as explained in Raw Data Preparation Documentation (ESIw).
Analysis of Estradiol-treated MCF7 ChIP-seq was performed
Fig. 1 Demonstration of the score flow operation on a three step
hypothetical pathway with final cellular activity processes (apoptosis,
cell cycle etc.). Raw data scores are shown in protein nodes in squares.
Protein A is the initiator protein, which transforms the 8/10 fraction
(10 is the sum of the scores of B and C) of its score to protein B and the
2/10 fraction to protein C. Then protein B gives out the sum of its raw
score plus the incoming score from A (+16 + 8 = 24) to proteins D
and E. Interaction with protein D is of inhibitory type, therefore protein
D’s incoming edge gets a negative value of 8. Hence, its target final
cellular process is inactive with a negative score (8 + 2 = 6). Other
target processes are active according to the accumulated scores.
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to determine the regulation role of the estrogen receptor
transcription factor in the MCF7 breast cancer cell line.
We performed a row-wise normalization on raw array data.
The gene expression experiments were provided as individual
rank I(x) scores for each node in the pathway.
The raw self-scores of nodes in the pathway were calculated
by the product of individual gene scores extracted from ChIP-
seq and expression array data by using the rank product
technique.21 The rank product method combines individual
ranks of different biological measurements.
SðxÞ ¼
YN
s¼1
IsðxÞ; ð1Þ
where Is(x) is the individual rank value of gene x coming from
the data source s, and N is the total number of heterogeneous
data sources. In order to integrate rank scores of genes
extracted from individual gene expression and the ChIP-seq
dataset, we applied eqn (1) and obtained the product of
individual ranks, where I1(x) and I2(x) represent the individual
ranking values of the microarray and ChIP-seq experiments
for the gene x, respectively. S(x) defines the raw self-score of
gene x. If both of the ranks of x were missing, S(x) value was set
to 0. If gene x in a pathway has several Entrez gene identifiers,
the mean of self-scores of these identifiers was calculated and
the mean value was assigned as the self-score of x.
Pathway scoring algorithm
A pathway is converted into a directed graph G = (V, E).
A node in the graph represents a gene product or a target
process linking the current signal to a final cellular activity.
The edges represent the relations (i.e., activation, inhibition)
between the nodes. In G, let outAdj(x) denote the out-
adjacency list of node x, that is, outAdj(x) = {y: (x,y) e E}
and let inAdj(x) denote the in-adjacency list of node x, that is,
inAdj(x) = {y: (y,x) e E}.
If an edge (x,y) from node x to y is labelled activation, the
total score of node x is then directly transferred. If edge (x,y) is
inhibition, the total score of node x is transferred with a
negative value as the score of node y. In order to consider
the processing order of the genes in the actual pathway map,
we performed score computations following the pathway
nodes. For this purpose, the directed graph is converted into
a cascade form by applying the multiple source breadth-first
search (BFS) algorithm, which effectively propagates BFS
levels starting from nodes of zero in-degree. Algorithm 1
displays the BFS-based algorithm used for this conversion.
This cascade form enables us to solve the score convergence
problems of some cyclic pathways.
Let V0,V1,V2,. . .,VL1 denote the levels of this cascade form
of G, where V0 denotes the set of nodes with zero in-degree.
Note that Vl contains the nodes whose shortest path distance
to the nodes in V0 is equal to l, for l = 1, 2,. . ., L  1. The
proposed approach adopts an iterative process that updates
the score of the nodes in a level-wise fashion. At each iteration
of the algorithm, the nodes of the graph are processed in level
order, i.e., the nodes in level l are processed before the nodes in
level l + 1. The processing of a node refers to transferring its
score to the nodes in its out-adjacency list. At iteration k, a
node x transfers its Skout to each node y in its out-adjacency list
according to the following equation:
f kðx; yÞ ¼ signðx; yÞ  SkoutðxÞ 
SðyÞP
z2outAdjðxÞ
SðzÞ ð2Þ
the out-score of node x is divided among the nodes in
outAdj(x) according to the raw self-scores of these nodes.
That is, nodes with small raw self-scores will get a small share
of Skout(x), compared to nodes having large self-scores. Note
that the type of the edge from x to y is defined by sign(x,y),
where sign(x,y) = 1 denotes activation and 1 denotes
inhibition. Hence, the out-score of a node x is updated at
each iteration k by summing up the out-score transfers from
the nodes in its in-adjacency list as:
SkoutðxÞ ¼ SðxÞ þ
X
z2inAdjðxÞ
f kðz; xÞ:
Algorithm 2 describes the general steps of pathway scoring.
In Algorithm 2, the for-loop inside the initialization for-loop
computes the sum of the raw self-scores of the nodes in the
out-adjacency of each node, which is equal to the denominator
term of eqn (2). The scheme adopted in the while-loop of the
score computation phase enables in-place accumulation of the
Fig. 2 Process diagram of the signal transduction score flow
algorithm.
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contributions of the out-score of a given vertex x to the out-
scores of the nodes in its adjacency list. Thus, the scheme
avoids the need for maintaining a flow value (see eqn (2)) for
each edge of graph G. The reason for the iterative approach is
the cyclic signalling pathways; the out-scores of the nodes in a
cycle need to be computed many times for the convergence of
node scores in the cycle. For this purpose, we execute the
while-loop until obtaining converged out-scores for all nodes
in the graph. The convergence on the out-score of a node x is
defined as:
SkoutðxÞ  Sk1out ðxÞ  e
where e is the error threshold for the convergence criteria and
is set to 106. Note that the proposed algorithm does not
necessitate the expensive cycle-finding process in graph G.
Instead, we performed passes over the entire graph level by
level (as indicated in pseudo code) to compute the converged
out-scores for all the nodes.
The graph G represents an overall pathway containing one
or more final biological processes. In G, different biological
processes are represented by a different subset of target nodes,
where the distinguishing property of a target node is having
zero out-degree. Let P denote the set of biological processes in
a pathway represented by G and let T(p) denote the subset of
target nodes representing biological processes p e P. The final
activity score for a biological process p is computed by taking
the sum of all possible biological processes leading to p in
pathway G:
StotðpÞ ¼
X
t2TðpÞ
SoutðtÞ
The BFS-based levelization/cascading algorithm runs in
linear time in the size of the pathway graph G. That is, it is
an O(V + E)-time algorithm. The while-loop of Algorithm 2
processes each vertex once, thus processing each edge only
once. The initialization for-loop of Algorithm 2 also makes a
single scan over all vertices and edges of G. So, Algorithm 2
can be considered as a linear-time algorithm if a constant
number of iterations suffice for convergence.
Significance analysis of activity scores
In order to determine significance of final activity scores, we
calculated the p-value of each activity score by applying input
data randomization. For this purpose, the score ratio of a
biological process z was defined as
SRðzÞ ¼ StotðzÞcontrol
StotðzÞexp
;
where Stot(z)control and Stot(z)exp are final activity scores of the
process z obtained with original control and experiment data,
respectively. The SR(z) value is crucial to identify which
experimental condition has more effect on the activity of a
specific process.
Randomization of the input data was performed as follows:
1. For each node j in a pathway, randomly select a gene
identifier k from the entire chip, then assign control and
experiment self-scores of gene k to node j.
2. Run the score flow algorithm with these random data.
3. Compute the new ratio score of each process obtained
with random data.
4. Repeat steps 1, 2 and 3 for M times.
The p-value P(z) of process z was calculated by taking
proportion of new ratio scores obtained with random data
that yield bigger or smaller scores than original SR(z)
PðzÞ ¼ 1
M
XM
n¼1
CðNRðzÞn; SRðzÞÞ;
where NR(z)n represents the new ratio score obtained with
randomized data at iteration n, and M is the total number of
iterations performed for the randomization procedure and
set to 10 000. The function C compares the values of SR(z)
and NR(z)n based on the magnitude of SR(z) and returns
either 0 or 1.
CðNRn; SRÞ ¼
1; if SRo 1 andNRn  SR
1; if SR4 1 andNRn  SR
0; otherwise
:
8<
:
We set significance threshold of P(z) to 0.1, hence the
activity score of the process is assumed to be significant for
an experiment if its p-value is less than this threshold.
Cytoscape plug-in
The score flow algorithm was implemented as Cytoscape
plug-in to make the algorithm publicly available for molecular
biologists. Cytoscape enables to visualize and to compute
activity score of each target process.13 In this environment,
the user can load manually curated and custom generated
pathways or upload KEGG pathways online. Each node in the
graph should contain a unique ID (assigned by Cytoscape),
NAME (process or gene name), ENTREZ ID (Entrez
gene Id), NODE TYPE (defined by the use i.e. ‘‘gene’’ or
‘‘activity process’’), TARGET PROCESS flag (for gene set to
‘‘no’’, for process ‘‘yes’’) and SCORE (initially set to zero,
then calculated by the Score Flow algorithm). Circle and
rectangle shapes represent the genes and target processes,
respectively.
The plugin requires two input files, first the above-mentioned
Cytoscape pathway file and the raw gene score file as tab
delimited text file. Each line of the score file contains three
attributes: Entrez id of gene, name and raw self-score. Upon
uploading both files, the signal transduction score flow algorithm
can be run over the pathway using Cytoscape plug-in’s menu
(Fig. 3). The calculated activity scores of genes and processes
can be exported in a tab delimited text file. The installation
and the step-by-step usage of the Cytoscape plug-in are given
as ESI.w
Results
Application of the score flow algorithm to paired transcriptome
and ChIP-seq data
Estrogen receptor (ER) is a hormonal transcription factor that
plays important roles in breast cancer development. Upon
binding to its ligand estrodiol, ER functions primarily through
binding to the transcription regulatory regions of target genes
containing the estrogen response element (ERE) consensus motifs.
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The set of experimental data that we analysed (from the
NCBI-GEO database; see Materials) was paired Estradiol
E2-treated MCF7 breast adenocarcinoma cells for ChIP-seq
and expression array data. After initial data integration and
the rank analysis of the raw ChIP-seq data, 1900 putative peak
regions neighbouring 485 genes from the array data were
identified. The raw gene scores were applied on KEGG path-
ways by using Cytoscape plug-in. The algorithm had to
run 10–15 times over the entire cyclic graph until it verified
the convergence threshold. The activity scores of significant
signalling pathways in MCF7 cells treated with Estradiol are
presented in Table 1. ER receptor activation in the estrogen-
receptor positive breast cancer cell line MCF7 was shown to be
clearly differentially activating the cellular processes involved
in Apoptosis in many cellular pathways. We also observed an
increased activity in Proliferation, Survival and Cell cycle end-
cellular processes (Table 1). This is in correlation with the
proliferative effect of E2 on MCF7 cells as also demonstrated
by previous studies.22–24 E2 carcinogenesis involves two
distinct pathways: oxidative metabolism of estrogen through
the Catechol Pathway and small GDP binding proteins with
MAPK pathway activation.25 Catechol Pathway leads to
apoptosis and MAPK signalling leads to survival and cell
proliferation. Our data analysis clearly demonstrates the
action of these two mechanisms in E2 treated MCF7 cells
when compared to untreated control cells.
In silico gene knockout operation on the PI3K/AKT pathway
Proteins residing in central positions in the network topology
and having many interactions with other proteins can be
considered hub-proteins. There are some proteins which act
as hubs, collecting high scores in our method as well. The
scores of target processes in a signalling cascade would be
affected by the deletion of such hub-nodes. With the aim of
determining the weights of such hub-nodes, we simply deleted
the hub-gene node and the in- and out-edges of that node from
the pathway and ran the algorithm again. The scored pathway
as a result of this gene knock-out operation was compared to
the original pathway’s scores. The significance of the final
activity scores was evaluated by randomization of input data.
After randomization, the p-value of the final activity scores in
knockout pathways was still consistent. Therefore, we were
able to assess the critical role of hub-proteins in high score
collecting nodes in a pathway leading to a cellular end process.
The in silico gene knock-out was applied on a PI3K/AKT
pathway, which was manually constructed using literature
information with Cytoscape (ESIw .cys file). The pathway
contains 83 genes, six target process nodes (DNA repair,
Translation,Migration, Angiogenesis, Apoptosis, andCell Cycle),
and 160 edges (105 activation and 55 inhibition) (ESIw, Fig. S1
and Cytoscape Files).
In the PI3K/AKT pathway, there are two significant hub
nodes: serine/threonine kinase Akt and tumour suppressor
gene p53. Akt promotes cell survival and had been shown to
be constitutively expressed in a variety of human tumours.26–28
p53 is an important hub-protein in cell signalling such as
apoptosis, cell cycle and DNA repair. Therefore, we decided
to knock out the p53 protein node from the native pathway.
After the in silico p53 knockout operation, the new pathway
was used during the score computation. The wild-type and in
silico p53-knocked out PI3K/Akt pathways were analysed
with an expression array dataset from adenocarcinoma
cell line Colo741 carrying oncogenic mutant form of KRas
(G12D) and the wild-type experiment control.20,29 Our score
flow algorithm provided comparative activity scores of original
and knockout pathways (Fig. 4).
As expected, the final activity score of the Apoptosis process
was significantly reduced in the p53 knockout pathway (Fig. 4C,
second row), confirming p53 as the key regulator of the
Apoptosis process (Fig. 4). In parallel the Cell Cycle process
was scored with increased activity. With the microarray data we
used, in which Ras mutations were studied in a BRAF mutated
context, the G12D mutation was also shown to be associated
with processes like cell cycle and apoptosis.26 In addition, no
change is observed in theDNA repair process because these cells
were not challenged to induce their DNA repair mechanism.
Discussion
The present study describes the novel signal transduction score
flow algorithm that not only computes the experimental data-
driven enrichment of the gene nodes and connecting edges of a
given cellular pathway but also provides the activity scores for
all target biological processes.
Due to the detailed node level biochemical data availability,
metabolic pathways were often dynamically modelled with
ordinary differential equations.30 Additionally flux balance
analysis using boolean expressions incorporated with ordinary
differential equations was used to simulate metabolic regulatory
pathways in an iterative approach similar to our algorithm.31
However lack of protein node stoichiometry knowledge in
cell signalling pathways is a major drawback in dynamic
modelling of the cell signalling networks using large scale
omics data.
Fig. 3 Cytoscape representation of the Jak-STAT pathway scored
with Estradiol-treated MCF7 cells data. The circles and rectangles
represent the genes and processes, respectively. The color intensity of
nodes from green to red represents the final gene enrichment or
process activity scores after the score flow algorithm is applied.
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In general, there are two approaches used to interpret the
large-scale experimental data after pre-processing. Usually the
scored or ranked gene categories based on the experimental
input are mapped on static cellular signalling pathways.
According to the pathway topology, the experiment-related
genes or gene sets are selected as differentially expressed genes
correlated with the observed phenotype.32 There are also studies
that use the pre-processed or raw high-throughput data to infer
molecular pathways related to the experiment. Therefore the
novel score flow algorithm presents a heuristic approach that
uses the gene score partition as a solution for protein node
stoichiometry during dynamic scoring of the pathway of interest.
Compared to other tools, our algorithm performs a simulation
of cell signalling flow on the cyclic pathway topology rather than
assigning static gene scores to pathway nodes.
The data driven enrichment of pathway nodes and edges
can be computed on network topology using differentially
expressed gene data by various tools. In general, these tools
calculate a single pathway impact score or a list of enriched
genes from that pathway. SPIA and GSEA tools are the most
similar publicly available tools comparable to our algorithm.
Signalling Pathway Impact Analysis (SPIA) tool estimates the
impact of experimental perturbations on pathways and it
is implemented in R.33 SPIA aims to identify the enriched
pathways using differentially expressed genes and pathway
topological information. When compared to our method,
SPIA provides only a general behaviour of the pathway i.e.,
activation or inhibition without activity scores for pathway
nodes, edges and activity processes (ESIw, Table S1). Besides,
SPIA does not provide a visual graph representation of the
pathways whereas our algorithm can be applied on any hand-
curated pathway with its Cytoscape plug-in.
Gene Set Enrichment Analysis (GSEA) was also compared
with our algorithm on the Colo741-KRas dataset. Based on
the GSEA results, only Reactome Apoptosis gene set was
significantly enriched (ESIw, Tables S2 and S3).
There are also recent studies, which exploit high-throughput
data considering the flow of the cell signalling within a path-
way. In one of these studies, a signalling network is repre-
sented by an electrical circuit, where interactions are resistors,
proteins are interconnecting junctions and the information flow
analysis identifies hub-proteins in the interactome networks.34
Although the information score flow approach seems to be
similar to our signal transduction flow algorithm, we model
gene signals as the integrated scores and score flow is trans-
ferred into child nodes based on their edge types and self-score
states. Cyclic feedback loops are also not considered in pre-
vious studies.32,34 When the score flow algorithm is compared
to similar tools, the most significant difference is the stoichio-
metric concentration based score partition during the flow of
the signal and the implementation of the cyclic feedback loops
in the pathways.
Table 1 Significant activity scores of signaling pathways for control and estradiol (E2)-treated samples of MCF7 cells
Activity score of process
p-ValueKEGG pathway Final process Control ER
Acute myeloid leukaemia (hsa05221) Proliferation 49 929 0.034
Alzheimer’s disease (hsa05010) Apoptosis 54 552 0.037
Apoptosis (hsa04210) Apoptosis 168 1354 0.050
Degradation 56 653 0.023
Chronic myeloid leukaemia (hsa05220) Proliferation 137 68 0.004
Endometrial cancer (hsa05213) Cell growth 131 63 0.006
Proliferation 163 94 0.004
ErbB signalling (hsa04012) Degradation 6 5 0.022
Focal adhesion (hsa04510) Apoptosis 37 161 0.053
Cell motility/FA formation 38 172 0.052
FA-turnover 27 708 0.016
Proliferation 66 257 0.045
Survival 23 165 0.025
Glioma (hsa05214) Cell growth 118 276 0.035
Jak-Stat signalling (hsa04630) Anti-apoptosis 41 118 0.048
Cell cycle 23 66 0.048
MAPK 24 86 0.029
Ubiquitin mediated proteolysis 6 12 0.033
MAPK signalling (hsa04010) Apoptosis 37 95 0.051
Cell cycle 62 1122 0.022
P53 signalling 22 46 0.062
Proliferation 156 1766 0.033
Wnt signaling 13 7 0.006
Melanoma (hsa05218) Survival 31 131 0.034
Neurotropic signalling (hsa04722) Plasticity 23 358 0.018
Regulation of actin cytoskeleton 25 359 0.037
Non-small cell lung cancer (hsa05223) Proliferation 160 91 0.004
Pathways in cancer (hsa05200) Block of differentiation 41 1052 0.009
Proliferation 239 1216 0.099
Regulation of actin cytoskeleton (hsa04810) Adherent junction 26 13 0.007
MAPK 109 2296 0.017
Renal cell carcinoma (hsa05211) Cell-junction, Migration, Invasion 147 627 0.055
Proliferation 149 80 0.004
Thyroid cancer (hsa05216) Proliferation 151 203 0.054
Survival 112 165 0.043
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In this study we also present the application of the tool on
datasets with complementary transcriptome and ChIP-seq
data. The results that we observed with the signal transduction
score flow algorithm were in correlation with the literature
data. Moreover, gene-level and global impacts of single or
multiple gene knockouts were examined by in silico knockout
analysis. The algorithm allows visualization of the impact of
deleting or inhibiting a protein node, not only on the first level
downstream protein but also related signalling pathways and
the various target cellular processes. Thus, it is possible to
visualize the side effects of inhibiting one protein, since its
influence on target processes other than the expected ones will
be demonstrated as well. It would be of great value to be able
to predict the drug combination that could not only increase
apoptosis in cancer cells but also decrease survival and cell
cycle. This in silico tool may suggest hypotheses about how a
drug of interest acts on the molecular cellular pathways, and it
may predict the synergistic effects of different inhibitors.
Algorithm 1
BFS-based algorithm for levelizing graph G.
Algorithm 2
Pathway scoring.
Fig. 4 Enrichment scores of apoptosis and cell cycle processes in the
manually curated PI3K/Akt pathway with KRas (G12D) mutation
data (A) and in silico p53-knockout (p53-KO) enrichment (B) with
Colo741 data. Activity scores of wildtype (wt) versus G12D mutation
are indicated in the table (C). Down-regulated and up-regulated genes
or processes are represented in color tones of green and red,
respectively.
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